Dissection of the pathologies induced by transmembrane and wild-type tumor necrosis factor in transgenic mice

被引:38
作者
Probert, L [1 ]
Akassoglou, K [1 ]
Alexopoulou, L [1 ]
Douni, E [1 ]
Haralambous, S [1 ]
Hill, S [1 ]
Kassiotis, G [1 ]
Kontoyiannis, D [1 ]
Pasparakis, M [1 ]
Plows, D [1 ]
Kollias, G [1 ]
机构
[1] HELLEN INST PASTEUR,DEPT MOLEC GENET,GR-11521 ATHENS,GREECE
关键词
autoimmunity; disease models; inflammation; neuroimmunology; arthritis; cytokine;
D O I
10.1002/jlb.59.4.518
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
With increasing awareness that seemingly diverse immune-mediated diseases involve similar pathogenetic mechanisms, and the identification of a growing number of key effector molecules, it is becoming possible to design and generate effective transgenic models for such diseases. Tumor necrosis factor (TNF) plays a prominent role in immune and host defense responses and there is strong evidence that abnormal TNF production contributes to disease initiation and progression in rheumatoid arthritis, systemic inflammatory response syndrome, diabetes, multiple sclerosis, and many other immune-mediated disorders. The generation of TNF transgenic mice, in which TNF production is deregulated, has provided us with direct evidence that, in vivo, this cytokine can indeed trigger the development of such complex disease phenotypes. Transgenic mice that have been engineered to overexpress human or murine TNF molecules in peripheral joints, T cells, or neurons of the central nervous system represent important animal models for human rheumatoid arthritis, systemic inflammation, and multiple sclerosis, respectively. In addition to establishing a central role for TNF in such diseases, these animal models have already proved valuable for identifying additional important disease-effector molecules, and for gaining an insight into the complex in vivo mechanisms that are involved in disease pathogenesis. For example, in the case of arthritis, TNF has been found to transmit its pathogenic effects entirely through interleukin-1, which may therefore represent an additional important target for therapeutic intervention in the human disease. In summary, TNF transgenic models of human disease are expected to serve as important in vivo tools for defining details of disease pathogenesis, potential targets for therapeutic intervention, and for evaluating the possible involvement of additional genetic and environmental factors on the disease state.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 94 条
[1]   STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS [J].
ADERKA, D ;
ENGELMANN, H ;
MAOR, Y ;
BRAKEBUSCH, C ;
WALLACH, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :323-329
[2]   BIOLOGY OF MULTIFUNCTIONAL CYTOKINES - IL-6 AND RELATED MOLECULES (IL-1 AND TNF) [J].
AKIRA, S ;
HIRANO, T ;
TAGA, T ;
KISHIMOTO, T .
FASEB JOURNAL, 1990, 4 (11) :2860-2867
[3]   THE SYNOVIUM OF TRANSGENIC ARTHRITIC MICE EXPRESSING HUMAN TUMOR-NECROSIS-FACTOR CONTAINS A HIGH-LEVEL OF NERVE GROWTH-FACTOR [J].
ALOE, L ;
PROBERT, L ;
KOLLIAS, G ;
BRACCILAUDIERO, L ;
SPILLANTINI, MG ;
LEVIMONTALCINI, R .
GROWTH FACTORS, 1993, 9 (02) :149-155
[4]  
ALOE L, 1993, INT J TISSUE REACT, V15, P139
[5]   THE 26-KD TRANSMEMBRANE FORM OF TUMOR-NECROSIS-FACTOR-ALPHA ON ACTIVATED CD4+ T-CELL CLONES PROVIDES A COSTIMULATORY SIGNAL FOR HUMAN B-CELL ACTIVATION [J].
AVERSA, G ;
PUNNONEN, J ;
DEVRIES, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) :1575-1585
[6]   CONTROL OF ESTABLISHED EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY INHIBITION OF TUMOR-NECROSIS-FACTOR (TNF) ACTIVITY WITHIN THE CENTRAL-NERVOUS-SYSTEM USING MONOCLONAL-ANTIBODIES AND TNF RECEPTOR IMMUNOGLOBULIN FUSION PROTEINS [J].
BAKER, D ;
BUTLER, D ;
SCALLON, BJ ;
ONEILL, JK ;
TURK, JL ;
FELDMANN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (09) :2040-2048
[7]   STIMULATION OF BONE-RESORPTION AND INHIBITION OF BONE-FORMATION INVITRO BY HUMAN-TUMOR NECROSIS FACTORS [J].
BERTOLINI, DR ;
NEDWIN, GE ;
BRINGMAN, TS ;
SMITH, DD ;
MUNDY, GR .
NATURE, 1986, 319 (6053) :516-518
[8]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[9]   RECOMBINANT TUMOR-NECROSIS-FACTOR INDUCES PROCOAGULANT ACTIVITY IN CULTURED HUMAN VASCULAR ENDOTHELIUM - CHARACTERIZATION AND COMPARISON WITH THE ACTIONS OF INTERLEUKIN-1 [J].
BEVILACQUA, MP ;
POBER, JS ;
MAJEAU, GR ;
FIERS, W ;
COTRAN, RS ;
GIMBRONE, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) :4533-4537
[10]   DISTRIBUTION AND CHARACTERIZATION OF TUMOR NECROSIS FACTOR-ALPHA-LIKE IMMUNOREACTIVITY IN THE MURINE CENTRAL-NERVOUS-SYSTEM [J].
BREDER, CD ;
TSUJIMOTO, M ;
TERANO, Y ;
SCOTT, DW ;
SAPER, CB .
JOURNAL OF COMPARATIVE NEUROLOGY, 1993, 337 (04) :543-567